Apr 7, 2022 | Featured, ICER, Statements
Flawed drug pricing approach fails to meet rare disease patient needs WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the Institute for Clinical and Economic Review’s (ICER) white paper, “The Next...
Read more
Jan 20, 2022 | Featured, Medicare Part D, Statements
WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the Department of Health and Human Services’ new report on prescription drug affordability for Medicare Part D patients: “Action must be taken to make...
Read more
Jan 12, 2022 | Statements
WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement on last week’s proposed CMS Rule, touted to lower costs for Medicare Part D beneficiaries at the pharmacy counter by giving patients the pharmacy price concessions...
Read more
Nov 8, 2021 | Health Insurance, Press Releases, Statements
HELP Act First Step to Patient-Centric Health Insurance Design WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement applauding the introduction of the bipartisan Help Ensure Lower Patient (HELP) Copays Act by U.S....
Read more
Jun 30, 2021 | News, Statements
There are 144 million Americans with chronic disease at stake. Instead of playing Washington D.C. political games with expensive opposition research collected to shame passionate hard-working patient advocates and advocacy organizations, David Mitchell and Patients...
Read more
